🧬 Could a new form of amyloid aggregation change how we understand Alzheimer’s disease?
🔗 Aggregation dynamics of a 150 kDa Aβ42 oligomer: Insights from cryo electron microscopy and multimodal analysis. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2024.11.024
📚 CSBJ: https://www.csbj.org/
#CryoEM #ProteinAggregation #Biophysics #StructuralBiology #AlzheimersResearch #Neuroscience #DrugDiscovery #AmyloidBeta
#ProteinAggregation is a hallmark of
#neurodegeneration. This study shows that HAPLN2 aggregates in the aging brain, triggering
#inflammation; microglial clearance regulates HAPLN2 buildup. This links protein accumulation to immune activation in healthy
#aging @PLOSBiology https://plos.io/4fJy7YG 
CANYA AI Decodes the Language of Sticky Proteins | Geekoo
A groundbreaking AI model trained on 100,000 synthetic protein sequences reveals new insights into what makes proteins clump, opening the door to better drugs and deeper understanding of diseases like Alzheimer’s.
Geekoo
A new way to measure ageing and disease risk with the protein aggregation clock

A new way to measure ageing and disease risk with the protein aggregation clock

Neues Verständnis von Altern und Krankheitsrisiko mithilfe der Proteinaggregationsuhr
Failure of
#ProteinQC in
#Celegans triggers a mechanism involving pathogen response factors &
#lysosome-mediated degradation, promoting tissue-specific resilience to age-dependent
#ProteinAggregation &
#proteotoxicity @DellaDavid_Lab &co
#PLOSBiology https://plos.io/44QeDdD
A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans
This study shows that during failure of core protein quality control in C. elegans, a specialized anti-aggregation mechanism relying on intracellular pathogen response factors and lysosomal mediated degradation is triggered, promoting tissue-specific resilience to age-dependent protein aggregation and its proteotoxicity.

Dementia risk linked to blood-protein imbalance in middle age
Abnormal levels of certain proteins — many of which have roles outside the brain — could be an early hallmark of Alzheimer’s disease or similar conditions.